期刊文献+

兔抗重组人钙网蛋白抗体的制备及其特性鉴定 被引量:2

Preparation of rabbit anti-recombinant human calreticulin antibody and its characterization
下载PDF
导出
摘要 目的:制备兔抗人钙网蛋白抗体并进行特性鉴定。方法:用PCR法扩增人钙网蛋白(CRT)基因,并克隆至pET32a表达载体中。以重组质粒pET32a/hCRT转化大肠杆菌BL-21(DE3),用IPTG诱导重组蛋白的表达,通过Ni2+-NTA琼脂糖凝胶柱亲和层析纯化目的蛋白。以纯化的hCRT为免疫原免疫新西兰大白兔制备抗体,用ELISA法、Westernblot和免疫组化染色法检测抗体的效价和特异性。结果:成功地表达并纯化hCRT重组蛋白。以纯化的重组hCRT免疫新西兰大白兔制备的抗体,ELISA检测其效价为1∶51 200,Western blot分析显示,该抗体能与hCRT特异性结合。免疫组化染色法检测结果表明,该抗体能识别天然的hCRT。结论:以重组hCRT为免疫原,成功地制备效价高、特异性好的兔抗hCRT抗体,为进一步进行钙网蛋白的检测及其临床应用研究奠定了基础。 AIM: To prepare the rabbit anti-recombinant human calreticulin(hCRT) antibody and its characterization.METHODS: The gene coding for hCRT was amplified by PCR and cloned into prokaryotic expression vector pET32a.Then the recombinant plasmid pET32a/hCRT was transformed into E.coli BL21(DE3) and expressed under IPTG induction.The recombinant hCRT was purified through Ni2+-NT agarose gel column and the purified hCRT used as immunogen to immunize the rabbit.The titer and specificity of the rabbit anti-hCRT antibody were analyzed by ELISA,Western blot and immunohistochemical staining,respectively.RESULTS: The recombinant hCRT was successfully expressed and purified,and the polyclonal anit-hCRT antibody was successfully prepared.The titer of the antiserum was 1∶51 200 by ELISA.Western blot analysis showed that the antibody reacted specifically to hCRT.Immunohistochemical staining detection manifested the antibody could recognize the native hCRT.CONCLUSION: The rabbit anti-hCRT antibody with high titer and specificity has been successfully prepared,which lays the foundation for further research on detection of hCRT and its clinical application.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2011年第6期641-643,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 广东省湛江市科技招标项目(2007年度) 广东省医学科研基金项目(A2008653)
关键词 钙网蛋白 表达 抗体 制备 calreticulin expression antibody preparation rabbit
  • 相关文献

参考文献9

  • 1Gold LI, Eggleton P, Sweetwyne MT, et aL Calreticulin: non-endoplasmic reticulum functions in physiology and disease[J]. FASEB J, 2010.24(3): 665-683.
  • 2Kageyama S, Isono T, Iwaki H, et al. Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine [J]. Clin Chem, 2004, 50(5) : 857 -866.
  • 3Chen CN, Chang CC, Su TE, et al. Identification of calreticulin as a prognosis marker and angiogenic regulator in human gastric cancer [J]. Ann Surg Oncol, 2009, 16(2) : 524 -533.
  • 4Zitvogel L, Kepp O, Senovilla L, et al. Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway [ J ]. Clin Ccancer Res, 2010, 16(12) : 3100 -3104.
  • 5陈章权,何素辉,陆田田,何天文,何韶衡.兔抗人肥大细胞羧肽酶抗体的制备与鉴定[J].细胞与分子免疫学杂志,2007,23(9):859-861. 被引量:10
  • 6Chignard N, Shang S, Wang H, et al. Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated frag-ments in patient sera[J]. Gastroenterology, 2006, 130 (7) : 2010 - 2022.
  • 7Vougas K, Gaitanarou E, Marinos E, et al. Two-dimensional electrophoresis and immunohistochemical study of calreticulin in colorectal adenocarcinoma and mirror biopsies[J]. J BUON, 2008, 13 ( 1 ) : 101 - 107.
  • 8Eric A, Juranic Z, Milovanovic Z, et al. Effects of humoral immunity and calreticulin overexpression on postoperative course in breast cancer [J]. Pathol Oncol Res, 2009, 15(1): 89 -90.
  • 9Chen CN, Chang CC, Su TE, et al. Identification of calreticulin as a prognosis marker and angiogenic regulator in human gastric cancer [J]. Ann Surg Oncol, 2009, 16(2) : 524 -533.

二级参考文献8

  • 1Payne V,Kam PC.Mast cell tryptase:A review of its physiology and clinical significance[J].Anaesthesia,2004,59(7):695-703.
  • 2Goldstein SM,Leong J,Schwartz LB,et al.Protease composition of excytosed human skin mast cell protease-proteoglycan complexes[J].J Immunol,1992,148(8):2475-2482.
  • 3Palczynski C,Walusiak J,Krakowiak A,et al.Nasal lavage fluid examination in diagnostics of occupational allergy to chloramine[J].Int J Occup Med Environ Health,2003,16(3):231-240.
  • 4Nishio H,Suzuki K.Serum tryptase levels in sudden infant death syndrome in forensic autopsy autopsy cases[J].Forensic Sci Int,2004,139(1):57-60.
  • 5Goldstein SM,Kaempfer CE,Kealey JT,et al.Human mast cell carboxypeptidase:Purification and characterization[J].J Clin Invest,1989,83(5):1630-1636.
  • 6Nallamsetty S,Austin BP,Penrose KJ,et al.Gateway vectors for the production of combinatorially tagged His6-MBP fusion proteins in the cytoplasm and periplasm of Escherichia coli[J].Protein Sci,2005,14(12):2964-2971.
  • 7Reynolds DS,Gurley DS,Austen KF,et al.Cloning and characterization of the novel gene for mast cell carboxypeptidase A[J].J Clin Invest,1992,89(1):273-282.
  • 8陈章权,何韶衡,陶爱林.人肥大细胞羧肽酶编码区基因的克隆与鉴定[J].细胞与分子免疫学杂志,2004,20(1):37-38. 被引量:3

共引文献9

同被引文献21

  • 1Jahangir Abdi,Bahram Kazemi,Mohammad Hasan Karimfar,Mohammad Bagher Rokni.Evaluation of rabbit antibody response against 8 and 16 kDa recombinant subunits of antigen B from Echinococcus granulosus[J].Asian Pacific Journal of Tropical Medicine,2012,5(5):355-357. 被引量:3
  • 2董丽,许青霞.尿中Cy21.1在膀胱癌诊断中应用[J].实用医技杂志,2006,13(1):54-54. 被引量:2
  • 3Antor AF, Hartge P, Hoover RN, et al. Epidemiological character istie of squamous cell carcinoma and adenocarcinoma of the blad der[J]. Cancer Res,1998,48(13) :3853-3855.
  • 4Gray M,Sims TW. NMP-22 for bladder cancer screening and sur veillance[J]. Urol Nurs,2004,24(3) : 171-172.
  • 5Kageyama S, Isono T, Iwaki H, et al. Identification by proteomic analysis of calretieulin as a marker for bladder cancer and evalua- tion of the diagnostic accuracy of its detection in urine[J]. Clin Chem, 2004,50 (5) : 857-866.
  • 6Gelebart P, Opas M, Michalak ML. Calreticulin, a Ca +-binding chaperone of the endoplasrnic reticulm[J]. Int J Bioehem Cell Biol, 2005,37 (2) : 260-266.
  • 7Iwaki H,Kageyama S,Isono T,et al. Diagnostic potential in blad der cancer of a panel of tumor markers(calreticulin,gamma-synu clein,and catechol-o-methyltransferase) identified by proteomic a nalysis[J]. Cancer Sci,2004,95(12) :955-961.
  • 8Dey P. Urinary markers of bladder carcinoma[J]. Clin Chem Ac ta, 2004,340(12) : 803-810.
  • 9Ecke TH. Focus on urinary bladder cancer markers: a review[J]. Minerva Urol Nefrol,2008,60(4):237-246.
  • 10Eissa S, Kenawy G, Swellam M, et al. Compararison of eytokera- tin 20 RNA and angiogenin in voided urine samples as diagnostic tools for bladder careinoma[J]. Clin Bioehem, 2004,37 (9) : 803- 810.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部